EADV 2024 Insights
Playback speed
10 seconds
EADV 2024 Insights: Change In Patient-Reported Hair Satisfaction During Deuruxolitinib Treatment of Severe Alopecia Areata: Pooled Data From The Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials
By
EADV 2024 Insights
FEATURING
Paradi Mirmirani
By
EADV 2024 Insights
FEATURING
Paradi Mirmirani
75 views
October 17, 2024
Comments 0
Login to view comments.
Click here to Login
Videos